Literature DB >> 2442254

Antigenic analysis of the repeat domain of the circumsporozoite protein of Plasmodium vivax.

P Romero, E P Heimer, S Herrera, A M Felix, R S Nussenzweig, F Zavala.   

Abstract

In the present study we analyzed the fine specificity of mouse monoclonal and human polyclonal antibodies directed against the repeat domain of the circumsporozoite (CS) protein of the human malaria parasite, Plasmodium vivax. Five synthetic peptides, representing monomeric and dimeric repeats of this malarial antigen, were assayed for their capacity to inhibit the binding of these antibodies to a yeast-derived recombinant CS protein. The results revealed the existence of at least two distinct repeated overlapping epitopes in the CS protein of P. vivax. Furthermore, polyclonal sera contain antibodies which recognize additional determinants not represented by the synthetic repeat peptides. Some of these sera contain antibodies recognizing a region flanking the repeat domain (region I). The present findings are in contrast with the antibody response in rodents and humans to the Plasmodium falciparum CS protein, which is directed against a single repeated immunodominant epitope.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442254

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Natural antibody responses against the non-repeat-sequence-based B-cell epitopes of the Plasmodium falciparum circumsporozoite protein.

Authors:  Y P Shi; V Udhayakumar; M P Alpers; M M Povoa; A J Oloo; T K Ruebush; A A Lal
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

2.  Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy.

Authors:  Diego A Espinosa; Anjali Yadava; Evelina Angov; Paul L Maurizio; Christian F Ockenhouse; Fidel Zavala
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

3.  Antibody response of humans to the circumsporozoite protein of Plasmodium vivax.

Authors:  E D Franke; C M Lucas; E San Roman
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.